指南与共识冠心病

2016年ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS冠状动脉血运重建适用标准:急性冠脉综合征患者

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular
指南 / 共识 · J Am Coll Cardiol · 2016-12-21

美国心脏病学会等多家学会对冠状动脉血运重建适用标准(AUC)进行两部分修订,本文为急性冠脉综合征(ACS)部分。写作委员会制定17个临床场景,由独立评级小组按1-9分评分,其中10个评为适用、6个可能适用、1个罕见适用。ST段抬高型心肌梗死和非ST段抬高型心肌梗死场景的血运重建均被认为适用。

要点

  • ACS血运重建AUC将场景评分7-9分定为适用,4-6分为可能适用,1-3分为罕见适用。
  • 17个临床场景中10个评为适用、6个可能适用、1个罕见适用。
  • ST段抬高型心肌梗死和非ST段抬高型心肌梗死场景的血运重建均评为适用。

核心结论

  • 本AUC为评估急性冠脉综合征患者冠状动脉血运重建实践模式提供框架,以期改善医生决策。

研究设计与样本

  • 由美国心脏病学会、心血管造影和介入学会、胸外科医师学会和胸外科协会等学会完成冠状动脉血运重建AUC的两部分修订,本文为ACS部分。
  • 写作委员会制定17个模拟日常实践的临床场景,由独立评级小组按1-9分评分。

主要发现

  • 17个临床场景中10个评为适用、6个可能适用、1个罕见适用。
  • ST段抬高型心肌梗死和非ST段抬高型心肌梗死场景的血运重建均评为适用。
  • 不稳定型心绞痛且具有中危或高危特征的场景评为适用。
  • 非罪犯动脉病变的管理和血运重建时机也被评级。

关键数值与推荐

  • 评分7-9分表示血运重建对该临床场景适用。
  • 评分1-3分表示血运重建对该临床场景罕见适用。
  • 评分4-6分表示冠状动脉血运重建对该临床场景可能适用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The American College of Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, and American Association for Thoracic Surgery, along with key specialty and subspecialty societies, have completed a 2-part revision of the appropriate use criteria (AUC) for coronary revascularization. In prior coronary revascularization AUC documents, indications for revascularization in acute coronary syndromes (ACS) and stable ischemic heart disease were combined into 1 document. To address the expanding clinical indications for coronary revascularization, and in an effort to align the subject matter with the most current American College of Cardiology/American Heart Association guidelines, the new AUC for coronary artery revascularization were separated into 2 documents addressing ACS and stable ischemic heart disease individually. This document presents the AUC for ACS. Clinical scenarios were developed to mimic patient presentations encountered in everyday practice and included information on symptom status, presence of clinical instability or ongoing ischemic symptoms, prior reperfusion therapy, risk level as assessed by noninvasive testing, fractional flow reserve testing, and coronary anatomy. This update provides a reassessment of clinical scenarios that the writing group felt to be affected by significant changes in the medical literature or gaps from prior criteria. The methodology used in this update is similar to the initial document but employs the recent modifications in the methods for developing AUC, most notably, alterations in the nomenclature for appropriate use categorization. A separate, independent rating panel scored the clinical scenarios on a scale of 1 to 9. Scores of 7 to 9 indicate that revascularization is considered appropriate for the clinical scenario presented. Scores of 1 to 3 indicate that revascularization is considered rarely appropriate for the clinical scenario, whereas scores in the mid-range (4 to 6) indicate that coronary revascularization may be appropriate for the clinical scenario. Seventeen clinical scenarios were developed by a writing committee and scored by the rating panel: 10 were identified as appropriate, 6 as may be appropriate, and 1 as rarely appropriate. As seen with the prior coronary revascularization AUC, revascularization in clinical scenarios with ST-segment elevation myocardial infarction and non–ST-segment elevation myocardial infarction were considered appropriate. Likewise, clinical scenarios with unstable angina and intermediate- or high-risk features were deemed appropriate. Additionally, the management of nonculprit artery disease and the timing of revascularization are now also rated. The primary objective of the AUC is to provide a framework for the assessment of practice patterns that will hopefully improve physician decision making.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2016. PMID: 28012615. doi:10.1016/j.jacc.2016.10.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。